skip to content

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

Media

Media releases
view all

stay updated

get the latest news and updates to your inbox.